| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/14/2007 | US20070135444 Treatment of neuroblastoma |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135414 Tachykinin Antagonists |
| 06/14/2007 | US20070135413 Treatment of glial tumors with glutamate antagonists |
| 06/14/2007 | US20070135409 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135337 Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
| 06/14/2007 | US20070134654 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 06/14/2007 | US20070134328 Oxymorphone controlled release formulations |
| 06/14/2007 | US20070134260 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134213 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 06/14/2007 | US20070134164 Fentanyl composition for nasal administration |
| 06/14/2007 | CA2632673A1 Use of a cb1 antagonist for treating negative symptoms of schizophrenia |
| 06/14/2007 | CA2632642A1 Novel diazabicyclic aryl derivatives and their medical use |
| 06/14/2007 | CA2631917A1 Quinolone m1 receptor positive allosteric modulators |
| 06/14/2007 | CA2631885A1 Xanthine derivatives, processes for preparing them and their uses |
| 06/14/2007 | CA2631643A1 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 06/14/2007 | CA2631128A1 Tricyclic amide derivatives useful for treating obesity |
| 06/14/2007 | CA2630595A1 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | CA2630417A1 Quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | CA2621866A1 Stable solid formulation of sertindole |
| 06/14/2007 | CA2621854A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 06/13/2007 | EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative |
| 06/13/2007 | EP1795524A1 Cyclic amine derivative or salt thereof |
| 06/13/2007 | EP1795199A2 Quetiapine for the treatment of substance dependence or substance abuse |
| 06/13/2007 | EP1795194A2 Use of an antagonist of CB1 receivers associated with a beta3-agonist for preparing medication to be used for treating appetence |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1795189A2 Method of administering buprenorphine to treat depression |
| 06/13/2007 | EP1794288A1 The modulation of phagocytosis in neurons |
| 06/13/2007 | EP1794160A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors |
| 06/13/2007 | EP1794157A1 2-acylaminothiazole derivatives |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794146A2 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 06/13/2007 | EP1794143A1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 06/13/2007 | EP1794126A1 Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| 06/13/2007 | EP1794125A1 Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation |
| 06/13/2007 | EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 06/13/2007 | EP1794115A2 N-ethyl hydroxyethylamines useful in treating cns conditions |
| 06/13/2007 | EP1793854A1 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 06/13/2007 | EP1793842A2 Treatment for cancer-related fatigue |
| 06/13/2007 | EP1793829A1 Use of pharmaceutical compositions of lofepramine for the treatment of adhd, cfs, fm and depression |
| 06/13/2007 | EP1793821A2 Pyrazolone compounds for treating cerebrovascular disorders |
| 06/13/2007 | EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 06/13/2007 | EP1793817A2 Methods of treating a disorder |
| 06/13/2007 | EP1793816A2 Compositions for treating amyloid associated diseases |
| 06/13/2007 | EP1534709B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1437353B1 Alkyl ether derivatives or salts thereof |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1381352B1 Transdermal patch for administering fentanyl |
| 06/13/2007 | EP1379546B1 Peptide for the diagnosis and therapy of alzheimer's disease |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1292305B1 Use of l-threo methylphenidate for the manufacture of a medicament for the treatment of psychotic disorders |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1173548B1 Materials and methods for the production of dopaminergic neurons |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | CN1980931A Compounds with atypical antipsychotic activity. |
| 06/13/2007 | CN1980929A 4-substituted piperidine derivatives |
| 06/13/2007 | CN1980924A Dihydrotetrabenazines and pharmaceutical compositions containing them. |
| 06/13/2007 | CN1980923A Polycyclic pyridines as potassium ion channel modulators |
| 06/13/2007 | CN1980922A New compounds useful for treating CNS disorders |
| 06/13/2007 | CN1980901A Biaryl derivatives |
| 06/13/2007 | CN1980899A Quinazolinone derivatives as parp inhibitors |
| 06/13/2007 | CN1980710A Substituted azepine derivatives as serotonin receptor modulators |
| 06/13/2007 | CN1980652A Medicament for preventing and/or treating sleep disorder |
| 06/13/2007 | CN1980648A Treating seizures using ICE inhibitors |
| 06/13/2007 | CN1978466A Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 06/13/2007 | CN1977976A Method for treating nerve injury and vector construct for the same |
| 06/13/2007 | CN1977951A Gastrodia elata plant extract for preventing senile dementia and its preparing method |
| 06/13/2007 | CN1977918A Venous preparation and its preparing method |
| 06/13/2007 | CN1977903A Chinese medicine composition for treating dementia, and its preparation and use |
| 06/13/2007 | CN1977895A Chinese medicine composition for treating headache and its preparing method |
| 06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
| 06/13/2007 | CN1977890A Chinese medicine composition and its use |
| 06/13/2007 | CN1977878A Chinese medicine composition and its use |
| 06/13/2007 | CN1977868A Ginkgo biloba leaf total terpene lactone extract, and its preparing method, medicinal composition and use |
| 06/13/2007 | CN1977851A Helicidum sustained-release pellet and its preparing method |
| 06/13/2007 | CN1977848A Use of steroidal compound and total steroidal extract for preparing anti-depression drug |
| 06/13/2007 | CN1977845A Buspirone hydrochloride slow/controlled release micro pill |
| 06/13/2007 | CN1977840A Gingko total terpene lactone compounded medicinal composition, and its preparing method and use |
| 06/13/2007 | CN1977831A Inclusion cyclodextrin/vanillin ex polar bear medicinal composition and its preparing method |
| 06/13/2007 | CN1977828A Injection preparation and use |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321112C Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker |
| 06/13/2007 | CN1321110C 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
| 06/13/2007 | CN1321106C New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 06/13/2007 | CN1320929C Agents for gene therapeutic for cerebrovascular disorders |
| 06/13/2007 | CN1320894C Application of H. erectum subsp. Longisepalum in preparation of health caring food |
| 06/13/2007 | CN1320893C Application of H. hubeiense in preparation of heath caring food |